Women’s libidos are about to get a shot in the arm thanks to a drug the Food and Drug Administration approved Friday.

The drug, called “Vyleesi,” treats low sexual desire through an auto-injector women use 45 minutes before having sex.

The drug, often referred to as the “female Viagra,” works by increasing dopamine in the body, a hormone that creates a feel-good sensation. It is meant to treat the roughly 10% of premenopausal women who have low sex drives, whose condition is officially known as “female hypoactive sexual desire disorder.”

Amag Pharmaceuticals Inc., the company marketing the product, said the condition “causes distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.”

The drug’s side effects include nausea, flushing, injection site reactions, and headache.

Vyleesi is the second sex-drive drug available for women since the FDA approved Addyi, a pill that women take daily, in 2015. Addyi has failed to gain the kind of traction and blockbuster status that came with Viagra, the drug that treats erectile dysfunction in men.

Amag which ran a social media campaign earlier this year called “unblush” that aimed to raise awareness about low sex drive in women.

Read More